Experienced in Interstitial Nephritis

Yi-wen T. Chiu

Kaohsiung, KHQ, TW 
Experienced in Interstitial Nephritis
Kaohsiung, KHQ, TW 
OverviewLocationsClinical Research

Overview

Yi-wen Chiu practices in Kaohsiung, Taiwan. Chiu is rated as an Experienced expert by MediFind in the treatment of Interstitial Nephritis. Their top areas of expertise are Chronic Kidney Disease, Diabetic Nephropathy, Metabolic Syndrome, Wilson Disease, and Kidney Transplant.

Their clinical research consists of co-authoring 171 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Interstitial Nephritis.

Locations

Kaohsiung, KHQ, Taiwan
Other Locations
Taitung, TNQ, Taiwan
TPQ, Taiwan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3 Study of PBF-1681 Comprising a 16-week, Placebo-controlled, Double-blind Randomized Period and an 8-week, Open-label Extension Period for the Treatment of Iron Deficiency Anemia in Patients With Non-Dialysis Dependent CKD
A Phase 3 Study of PBF-1681 Comprising a 16-week, Placebo-controlled, Double-blind Randomized Period and an 8-week, Open-label Extension Period for the Treatment of Iron Deficiency Anemia in Patients With Non-Dialysis Dependent CKD
Enrollment Status: Completed
Publish Date: June 29, 2025
Intervention Type: Drug
Study Drug: Ferric Citrate
Study Phase: Phase 3
A Long-Term, Open-Label, Prospective Phase IV Study to Assess the Safety and Efficacy of Nephoxil® in Subjects With End Stage Renal Disease (ESRD) on Dialysis
A Long-Term, Open-Label, Prospective Phase IV Study to Assess the Safety and Efficacy of Nephoxil® in Subjects With End Stage Renal Disease (ESRD) on Dialysis
Enrollment Status: Completed
Publish Date: January 13, 2020
Intervention Type: Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

171 Total Publications

Clinical efficacy and cost effectiveness of SGLT2i in diabetic nephropathy: a large population-based study.
Clinical efficacy and cost effectiveness of SGLT2i in diabetic nephropathy: a large population-based study.
Journal: Diabetes research and clinical practice
Published: June 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Chiu's expertise for a condition
ConditionClose
      View All 34 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile